118 related articles for article (PubMed ID: 38521010)
1. Insights into nucleoside hydrolase from Leishmania donovani inhibition: A new bioaffinity chromatography-based screening assay and docking studies.
Anchau Wegermann C; Santana Bezerra E; Gomes de Macedo Sant'Anna I; Ortega De Oliveira PC; da Costa Silva R; Rocco Machado T; Wanderley Tinoco L; Vieira de Souza MCB; Pascutti P; Santos Boechat FDC; de Moraes MC
Bioorg Chem; 2024 May; 146():107302. PubMed ID: 38521010
[TBL] [Abstract][Full Text] [Related]
2. Nucleoside hydrolase immobilized on magnetic particles as a tool for onflow screening and characterization of inhibitors.
de Oliveira PCO; Ceroullo MS; Dos Santos MB; Medeiros PRC; Marques BCB; Tinoco LW; de Souza MCBV; da Costa Santos Boechat F; de Moraes MC
J Pharm Biomed Anal; 2023 Oct; 235():115589. PubMed ID: 37531732
[TBL] [Abstract][Full Text] [Related]
3. High-resolution inhibition profiling and ligand fishing for screening of nucleoside hydrolase ligands in Moringa oleifera Lamarck.
de Faria RA; Oliveira PCO; de Carvalho MDP; Peixoto BS; Severino VGP; Tinoco LW; Rodrigues SV; de Moraes MC
J Pharm Biomed Anal; 2022 Mar; 211():114614. PubMed ID: 35123329
[TBL] [Abstract][Full Text] [Related]
4. An NMR-Based Chemometric Strategy to Identify
Casanova LM; Rodrigues LM; de Aguiar PF; Tinoco LW
J Nat Prod; 2020 Feb; 83(2):243-254. PubMed ID: 31985226
[TBL] [Abstract][Full Text] [Related]
5. A nonspecific nucleoside hydrolase from Leishmania donovani: implications for purine salvage by the parasite.
Cui L; Rajasekariah GR; Martin SK
Gene; 2001 Dec; 280(1-2):153-62. PubMed ID: 11738828
[TBL] [Abstract][Full Text] [Related]
6. Kinetics and docking studies of two potential new inhibitors of the nucleoside hydrolase from Leishmania donovani.
Rennó MN; França TC; Nico D; Palatnik-de-Sousa CB; Tinoco LW; Figueroa-Villar JD
Eur J Med Chem; 2012 Oct; 56():301-7. PubMed ID: 22947894
[TBL] [Abstract][Full Text] [Related]
7. New
Nirma C; Rangel GT; Alves MA; Casanova LM; Moreira MM; Rodrigues LM; Hamerski L; Tinoco LW
RSC Adv; 2019 Jun; 9(32):18663-18669. PubMed ID: 35515226
[TBL] [Abstract][Full Text] [Related]
8. Prediction and analysis of promiscuous T cell-epitopes derived from the vaccine candidate antigens of Leishmania donovani binding to MHC class-II alleles using in silico approach.
Kashyap M; Jaiswal V; Farooq U
Infect Genet Evol; 2017 Sep; 53():107-115. PubMed ID: 28549876
[TBL] [Abstract][Full Text] [Related]
9. The importance of nucleoside hydrolase enzyme (NH) in studies to treatment of Leishmania: A review.
Figueroa-Villar JD; Sales EM
Chem Biol Interact; 2017 Feb; 263():18-27. PubMed ID: 27939867
[TBL] [Abstract][Full Text] [Related]
10. A parasite rescue and transformation assay for antileishmanial screening against intracellular Leishmania donovani amastigotes in THP1 human acute monocytic leukemia cell line.
Jain SK; Sahu R; Walker LA; Tekwani BL
J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299097
[TBL] [Abstract][Full Text] [Related]
11. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK
Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy against visceral leishmaniasis with the nucleoside hydrolase-DNA vaccine of Leishmania donovani.
Gamboa-León R; Paraguai de Souza E; Borja-Cabrera GP; Santos FN; Myashiro LM; Pinheiro RO; Dumonteil E; Palatnik-de-Sousa CB
Vaccine; 2006 May; 24(22):4863-73. PubMed ID: 16635538
[TBL] [Abstract][Full Text] [Related]
13. Capillary bioreactors based on human purine nucleoside phosphorylase: a new approach for ligands identification and characterization.
de Moraes MC; Ducati RG; Donato AJ; Basso LA; Santos DS; Cardoso CL; Cass QB
J Chromatogr A; 2012 Apr; 1232():110-5. PubMed ID: 22099222
[TBL] [Abstract][Full Text] [Related]
14. Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis Multiplication In Vitro.
Freitas EO; Nico D; Guan R; Meyer-Fernandes JR; Clinch K; Evans GB; Tyler PC; Schramm VL; Palatnik-de-Sousa CB
PLoS One; 2015; 10(4):e0124183. PubMed ID: 25909893
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Leishmania promastigote growth in vitro by means of nucleoside hydrolase activity determination.
Garin YJ; Sulahian A; Meneceur P; Gangneux JP; Pannier-Stockman C; Derouin F
Parasitol Res; 2001 Feb; 87(2):145-8. PubMed ID: 11206112
[TBL] [Abstract][Full Text] [Related]
16. Nucleoside hydrolase from Leishmania (L.) donovani is an antigen diagnostic for visceral leishmaniasis.
Santana DM; Borja-Cabrera GP; Paraguai de Souza E; Sturm NR; Palatnik de Sousa CB; Campbell DA
Mol Biochem Parasitol; 2002 Apr; 120(2):315-9. PubMed ID: 11897139
[No Abstract] [Full Text] [Related]
17. Nucleoside Hydrolase NH 36: A Vital Enzyme for the
Palatnik-de-Sousa CB
Front Immunol; 2019; 10():813. PubMed ID: 31040850
[TBL] [Abstract][Full Text] [Related]
18. Screening of Novel Inhibitors Against Leishmania donovani Calcium ion Channel to Fight Leishmaniasis.
Kashif M; Manna PP; Akhter Y; Alaidarous M; Rub A
Infect Disord Drug Targets; 2017; 17(2):120-129. PubMed ID: 28034363
[TBL] [Abstract][Full Text] [Related]
19. Structural explanation for the tunable substrate specificity of an E. coli nucleoside hydrolase: insights from molecular dynamics simulations.
Lenz SAP; Wetmore SD
J Comput Aided Mol Des; 2018 Dec; 32(12):1375-1388. PubMed ID: 30478756
[TBL] [Abstract][Full Text] [Related]
20. Molecular docking, structure-activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani.
Kaur J; Sundar S; Singh N
J Antimicrob Chemother; 2010 Aug; 65(8):1742-8. PubMed ID: 20519355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
